Ranno 1986.
Methods | Double blinded: yes. | |
Participants | N=39 Italian men with symptomatic BPH. Mean age: 70 years. Lost to follow‐up: 0. | |
Interventions | Control: placebo (n=19). Treatment: P. africanum extract (Tadenan) 100 mg daily (n=20). Treatment duration: 2 months. | |
Outcomes | Nocturia; peak urine flow. Adverse events. | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | B ‐ Unclear |